Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Recombinant Human TWEAK protein (ab269089)

Recombinant Human TWEAK protein (ab269089)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: Escherichia coli
  • Purity: = 95% SDS-PAGE
  • Endotoxin level:
  • Suitable for: SDS-PAGE

You may also be interested in

Product image
Anti-IKK alpha antibody [Y463] (ab32041)
Product image
Recombinant Human PRP19 protein (BSA and azide free) (ab172187)
Product image
Anti-Caveolin-2 antibody - BSA and Azide free (Capture) (ab272305)
Product image
Anti-ARSG antibody (ab251745)

Preparation and Storage

  • APO 3 ligand
  • APO 3L
  • APO3 ligand

Images

  • SDS-PAGE - Recombinant TWEAK protein (ab269089)
    SDS-PAGE - Recombinant TWEAK protein (ab269089)

    SDS-PAGE analysis of ab269089.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Hemin Assay Kit (ab65332)

  •  
  • Product image

    Recombinant Human DIRAS1 protein (ab99389)

  •  
  • Product image

    VEGFA peptide (ab46160)

  •  
  • HIP1 peptide (ab188140)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.